A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions

Transplant Immunology

Volumn 7, Issue 4, 1999, Pages 239-246

  Lidington, E A ^a   Moyes, D L ^a   McCormack, A M ^a   Rose, M L ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD40 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CELL MIGRATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 0033401437     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(99)80008-2     Document Type: Article

References (32)

1. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA. 80:1983;3734-3737.
2. Ades EW, Candal FJ, Swerlick RA, et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 99:1992;683-690.
3. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T. Spontaneous transformation and immortalization of human endothelial cells in vitro. Cell Dev Biol. 26:1990;265-274.
4. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1991;1033-1036.
5. Pober JS, Orosz CG, Rose ML, Savage CO. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation. 61:1996;343-349.
6. Ma W, Pober JS. Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol. 161:1998;2158-2167.
7. Savage CO, Brooks CJ, Harcourt GC, et al. Human vasacular endothelial cells process and present autoantigen to human T cell lines. Int Immunol. 7:1995;471-479.
8. Myers CL, Wertheimer SJ, Schembri King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol. 263:1992;C767-C772.
9. Renkonen R, Mattila P, Majuri ML, Paavonen T, Silvennoinen O. IL-4 decreases IFN-gamma-induced endothelial ICAM-1 expression by a transcriptional mechanism. Scand J Immunol. 35:1992;525-530.
10. Durieu Trautmann O, Chaverot N, Cazaubon S, Strosberg AD, Couraud PO. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem. 269:1994;12536-12540.
11. Lawson C, Ainsworth M, Yacoub M, Rose M. Ligation of ICAM-1 on endothelial cells lead to expression of VCAM-1 via an NF-kB independent mechanism. J Immunol. 162:1999;2990-2996.
12. Karmann K, Min W, Fanslow WC, Pober JS. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J Exp Med. 184:1996;173-182.
13. Kaplanski G, Farnarier C, Benoliel AM, Foa C, Kaplanski S, Bongrand P. A novel role for E- and P-selectins: shape control of endothelial cell monolayers. J Cell Sci. 107:1994;2449-2457.
14. Lu TT, Yan LG, Madri JA. Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA. 93:1996;11808-11813.
15. Dong C, Wilson JE, Winters GL, McManus BM. Human trasnplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest. 74:1996;921-931.
16. Yang Z, Von Segesser L, Bauer E, Stulz P, Turina M, Luscher TF. Different activation of the endothelial L-arginine and cyclo-oxygenase pathway in the internal mammary artery and saphenous vein. Circ Res. 68:1991;52-60.
17. Page C, Rose M, Yacoub MH, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol. 141:1992;673-683.
18. Swerlick RA, Lee KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol. 149:1992;698-705.
19. Petzelbauer P, Bender JR, Wilson J, Pober JS. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol. 151:1993;5062-5072.
20. Haraldson G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. Cytokine regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhsion molecule (VCAM-1) in human intestinal microvascular endothelial cells. J Immunol. 156:1996;2558-2567.
21. McDouall RM, Batten P, McCormack A, Yacoub MH, Rose ML. MHC class II expression on human heart microvascular endothelial cells: exquisite sensitivity to interferon-gamma and natural killer cells. Transplantation. 64:1997;1175-1180.
22. Mutin M, George G, Lesaule G, Sampol J. Re-evaluation of Trypsin-EDTA for endothelial cell detachment before flow cytometry analysis. Endothelium. 4:1996;289-295.
23. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 52:1973;2745-2756.
24. Lidington E, Nohammer C, Dominguez M, Ferry B, Rose ML. Inhibition of the transendothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibitors. Clin Exp Immunol. 104:1996;66-71.
25. Lee YJ, Benveniste EN. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. J Immunol. 157:1996;1559-1568.
26. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 75:1993;135-146.
27. Chang CH, Fontes J, Peterlin M, Flavell R. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med. 180:1994;1367-1375.
28. Yago T, Tsukuda M, Yamazaki H, Nishi T, Amano T, Minami M. Analysis of an initial step of T cell adhesion to endothelial monolayers under flow conditions. J Immunol. 154:1995;1216-1222.
29. Thornhill MH, Li J, Haskard DO. Leucocyte endothelial cell adhesion: a study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926. Scand J Immunol. 38:1993;279-286.
30. Xu Y, Swerlick RA, Sepp N, Bosse D, Ades EW, Lawley TJ. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol. 102:1994;833-837.
31. Hughes SE. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp Cell Res. 225:1996;171-185.
32. Collins T, Korman AJ, Wake CT, et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA. 81:1984;4917-4921.